{"schema_version":"secwatch.filing_event.v1","accession":"0001372514-24-000068","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.817487+00:00","generated_at":"2026-05-31T23:57:55.402270+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Kiora appoints Walters-Hoffert to board, promotes Tosca to CFO, regains Nasdaq compliance","bullets":["Lisa Walters-Hoffert appointed independent director and audit committee chair; Kenneth Gayron resigned.","Melissa Tosca promoted from EVP of Finance to CFO; salary raised to $337,000, bonus target to 40%.","CEO Brian Strem's salary increased to $569,000 (55% bonus); Chief Development Officer Daniels to $443,000 (40%).","New non-employee director compensation: initial 1,778 stock option grant, cash retainers up to $70,000 annually.","Regained compliance with Nasdaq minimum bid price rule (Nasdaq Listing Rule 5550(a)(2)) as of June 28, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001372514-24-000068","json":"https://secwatch.observer/filing/0001372514-24-000068.json","markdown":"https://secwatch.observer/filing/0001372514-24-000068.md","text":"https://secwatch.observer/filing/0001372514-24-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000068/0001372514-24-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000068/kprx-20240628.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:57:55.402270+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}